Hold Marksans Pharma, says Sharmila Joshi

Sharmila Joshi of sharmilajoshi.com told CNBC-TV18, "I do not have a short-term view on Marksans Pharma, but for a couple of years and the business that there are in is actually what I am positive on, the soft gel space. The opportunities in that are good. And also, the fact that they are exporting to the good geographies."

"I would be positive on the stock. Of course unfortunately, as we all know, the stock has really done nothing for the last year, year and a half and I had probably recommended it at a much higher price. One can hold on for a couple of years," she added.